Abstract:Background: To explore the clinical significance of miR-125b-5p and its potential mechanisms in lung squamous cell carcinoma (LUSC). Materials and Methods: An integrated analysis of data from in-house quantitative real-time polymerase chain reaction (qRT-PCR), microRNA-sequencing, and microarray assays to appraise the expression level of miR-125b-5p in LUSC tissues compared to adjacent noncancerous controls. The authors identified the candidate targets of miR-125b-5p and conducted functional analysis using computational biology strategies from gene ontology, the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, disease ontology (DO), and protein-protein interaction (PPI) network analyses to investigate the prospective mechanisms. Results: According to qRT-PCR results, the expression level of miR-125b-5p was markedly decreased in LUSC tissues compared to noncancerous control tissues. Receiver operating characteristic and summary receiver operating characteristic analyses showed that miR-125b-5p had good specificity and sensitivity for distinguishing LUSC tissue from noncancerous lung tissue. The standard mean difference revealed that men and women with lower expression levels of miR-125b-5p may have a higher risk for LUSC. KEGG analysis and DO analysis intimated that target genes were evidently enriched in pyrimidine metabolism and pancreatic carcinoma. The PPI network of the top assembled KEGG pathway indicated that RRM2, UMPS, UCK2, and CTPS1 were regarded as crucial target genes for miR-125b-5p, and RRM2 was eventually deemed a key target. Conclusions: The authors' findings implicate a low expression level of miR-125b-5p in LUSC. A tumor-suppressive role of miR-125b-5p is proposed, based on its effects on LUSC tumor growth, clinical stage progression, and lymph node metastasis.

Progress on the Relationship Between Mir-125 Family and Tumorigenesis

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

MicroRNA-125 in Immunity and Cancer.

MiR-125b Promotes Cell Migration and Invasion by Targeting PPP1CA-Rb Signal Pathways in Gastric Cancer, Resulting in a Poor Prognosis

Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-Oncogene in Human Invasive Breast Cancer.

The Expression and Regulation of Microrna-125b in Cancers

Data from Mir-125B is Methylated and Functions As a Tumor Suppressor by Regulating the ETS1 Proto-oncogene in Human Invasive Breast Cancer

The potential role of miR-124-3p in tumorigenesis and other related diseases

Mir-125B Expression Affects Tumor Growth of Multiple Myeloma Via Targeting MKK7.

Downregulated Mir-1247-5p Associates with Poor Prognosis and Facilitates Tumor Cell Growth Via DVL1/Wnt/β-catenin Signaling in Breast Cancer

Ectopic Expression Of Mir-125a Inhibits The Proliferation And Metastasis Of Hepatocellular Carcinoma By Targeting Mmp11 And Vegf

Mir-125A-5p Inhibits Tumorigenesis in Hepatocellular Carcinoma.

MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT

MicroRNA-125b may function as an oncogene in lung cancer cells.

Mir-125B Inhibits Connexin43 and Promotes Glioma Growth

MicroRNA-125b Promotes Apoptosis by Regulating the Expression of Mcl-1, Bcl-w and IL-6R

Mir-1258 Attenuates Tumorigenesis Through Targeting E2F1 to Inhibit PCNA and MMP2 Transcription in Glioblastoma.

Roles and Mechanism of Mir-199A and Mir-125B in Tumor Angiogenesis

Downregulation of Mir-125B-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.

Mir-125B is Associated with Renal Cell Carcinoma Cell Migration, Invasion and Apoptosis

Effects of Microrna‑125b on Multiple Myeloma Cell Growth in Vitro and in Vivo.